Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports.

Mukesh Kumar Sah Bishnu Mohan Singh Puja Sinha Prerit Devkota Sudhira Kumari Yadav John Shrestha Ashis Shrestha

Published in: Journal of medical case reports (2022)

These cases reporting Superficial Vein Thrombosis may be an additional adverse effect to the list of adverse events associated with ChAdOx1 nCoV-19, Covishield, vaccine. However, the benefits of the vaccine in breaking the chain of COVID 19 spread are certainly greater than the risk of thromboses.

Keyphrases

coronavirus disease
sars cov
pulmonary embolism
adverse drug
case report
emergency department